Approval and initiation of clinical phase I/II study for the new COVID-19 vaccine developed by the team of Prof. Salanti

Share this post

We use cookies to improve the functionality, performance, and effectiveness of our website. Detailed information on the use of cookies is provided in our Privacy Policy and Terms of Use. By continuing to use this site, or by clicking “I agree” you consent to the use of cookies.